Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative diagnostic tool of 3D Printing – What are the clinical uses? Limitations? Research findings and future innovation.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Jerry Estep, Section Head of the George M. and Linda H. Kaufman Center for Heart Failure Treatment and Recovery and Brad Williams Pharm D, pharmacy specialist for heart failure about drug recalls. In light of the recent ARB recalls, these three medical experts discuss the ARB recall, how to keep current with new recalls, what physicians should do when a medication has been recalled, the challenges of generic medications, alternative medications for heart failure and hypertension, and when ARBs should be used.

Luke Laffin, MD, Medical Director of Cardiac Rehabilitation and cardiologist in the Section of Preventive Cardiology at Cleveland Clinic talks about two related abstracts recently presented at the American Heart Association’s Hypertension Scientific Sessions focused on resistant hypertension in a cardiac rehabilitation program. Dr. Laffin defines resistant hypertension, the prevalence of resistant hypertension in a cardiac rehabilitation setting, factors associated with patients who have resistant hypertension, and lessons learned about this patient population.

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery and Dr. Sean Lyden, MD, Chairman, Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute discuss the changes in operative strategies for aortic aneurysm repair. As the national trend shows an increase in EVAR and decline in open repair, is it time to review current training programs to see if there is a need for specialized training in complex open aortic repair in high volume centers?

Dr. Daniel Cantillon discusses their analysis of ECG recordings of over 24,000 patients from the PRECISION study. They found that left bundle branch block (LBBB) and left intraventricular conduction defect (LIVCD) is an important risk factor for increased mortality in patients at risk for cardiovascular disease.

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology and Chetan Huded MD, Interventional Fellow discuss incidence of stroke up to 30 days after TAVR. Dr. Huded published his findings in JAMA . Drs. Menon and Huded discuss the patient population, pulled from the TVT registry and what the findings mean for clinical practice.

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology discusses with Erika Hutt, MD a first year cardiovascular fellow the use of the WATCHMAN, a left atrial appendage closure device, in patients with prior intracranial hemorrhage. Her study was recently published in Heart Rhythm. Drs. Menon and Hutt talk about the study, the patient population as well as the findings and what this means for this patient population in the future.

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology talks with Eoin Donnellen MD, a third year cardiovascular fellow about the impact of radiation induced aortic stenosis on treatment. Dr. Donnellen first describes a paper looking at Aortic Valve Replacement in patients who had had mediastinal radiation vs. those who did not have radiation . His second study looked at outcomes of TAVR in patients with mediastinal radiation associated aortic stenosis. Drs. Menon and Donnellen discuss the findings of both studies and the clinical implications